Medicine
fromNews Center
1 day agoHow Inflammation Fuels Blood Cancer Risk - News Center
TP53-mutant hematopoietic stem cells gain advantage under chronic inflammation via NLRP1 inflammasome activation and altered RNA processing, driving clonal expansion and leukemia risk.